| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |